Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ZYME | 45.14% | $876.06M | +46.53% | 0.00% |
CRNX | 44.19% | $2.81B | -33.11% | 0.00% |
DAWN | 43.97% | $655.81M | -53.05% | 0.00% |
APGE | 43.49% | $2.58B | +10.24% | 0.00% |
RARE | 43.15% | $3.45B | -11.14% | 0.00% |
AUTL | 41.39% | $614.79M | -33.62% | 0.00% |
ACLX | 41.20% | $3.60B | +18.41% | 0.00% |
ELVN | 41.07% | $1.22B | -11.51% | 0.00% |
NRIX | 40.72% | $887.38M | -44.23% | 0.00% |
SNDX | 40.53% | $777.87M | -55.97% | 0.00% |
DYN | 40.25% | $1.09B | -72.88% | 0.00% |
KRYS | 40.10% | $4.01B | -24.37% | 0.00% |
CLDX | 39.98% | $1.35B | -45.18% | 0.00% |
RVMD | 39.31% | $6.88B | -4.90% | 0.00% |
MIRM | 39.07% | $2.53B | +49.43% | 0.00% |
ROIV | 38.94% | $7.74B | +7.76% | 0.00% |
IMVT | 38.62% | $2.75B | -39.02% | 0.00% |
IRON | 38.53% | $1.89B | +20.92% | 0.00% |
OCUL | 38.47% | $1.47B | +34.80% | 0.00% |
XNCR | 38.47% | $579.33M | -57.00% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DV | <0.01% | $2.41B | -23.78% | 0.00% |
SEG | 0.04% | $227.61M | -30.38% | 0.00% |
ACEL | -0.07% | $1.01B | +15.98% | 0.00% |
CROX | 0.08% | $5.78B | -29.41% | 0.00% |
SMWB | 0.09% | $629.50M | -2.19% | 0.00% |
EL | -0.14% | $28.81B | -24.73% | 2.14% |
SUZ | 0.15% | $11.52B | -6.49% | 0.00% |
CL | 0.19% | $71.89B | -8.58% | 2.28% |
DLTR | -0.20% | $20.60B | -7.56% | 0.00% |
NRDS | -0.27% | $814.42M | -25.14% | 0.00% |
HE | 0.27% | $1.84B | +18.07% | 0.00% |
TDC | -0.27% | $2.10B | -36.57% | 0.00% |
VHC | 0.31% | $45.90M | +59.26% | 0.00% |
SKX | 0.31% | $9.44B | -8.74% | 0.00% |
HSIC | 0.32% | $8.92B | +14.31% | 0.00% |
ETSY | 0.33% | $5.28B | -14.14% | 0.00% |
ZBH | 0.37% | $18.10B | -15.73% | 1.05% |
BHE | 0.37% | $1.42B | -0.46% | 1.72% |
AORT | 0.38% | $1.33B | +21.60% | 0.00% |
NKE | 0.39% | $106.33B | -4.42% | 2.20% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -22.02% | $165.69M | 0.85% |
TAIL | -21.02% | $99.76M | 0.59% |
BTAL | -16.84% | $296.79M | 1.43% |
CLIP | -13.60% | $1.52B | 0.07% |
CTA | -11.77% | $1.06B | 0.76% |
STOT | -11.51% | $253.88M | 0.45% |
TPMN | -8.84% | $30.81M | 0.65% |
USDU | -8.59% | $162.92M | 0.5% |
ULST | -8.08% | $662.59M | 0.2% |
GBIL | -7.70% | $6.38B | 0.12% |
UUP | -7.39% | $211.55M | 0.77% |
UNG | -7.38% | $359.91M | 1.06% |
TBLL | -7.15% | $2.13B | 0.08% |
TBIL | -6.81% | $5.84B | 0.15% |
BUXX | -6.37% | $318.71M | 0.25% |
KMLM | -5.63% | $188.31M | 0.9% |
XBIL | -4.49% | $783.57M | 0.15% |
XONE | -4.28% | $585.86M | 0.03% |
XHLF | -4.04% | $1.73B | 0.03% |
USFR | -3.94% | $18.51B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 51.51% | $4.95B | 0.35% |
GNOM | 45.34% | $44.43M | 0.5% |
IBB | 45.07% | $5.36B | 0.45% |
PTH | 41.35% | $101.07M | 0.6% |
PBE | 40.32% | $223.24M | 0.58% |
BBH | 39.77% | $329.82M | 0.35% |
FBT | 38.59% | $1.01B | 0.54% |
PINK | 37.28% | $133.06M | 0.5% |
ARKG | 35.29% | $1.05B | 0.75% |
XPH | 33.42% | $149.79M | 0.35% |
VHT | 30.86% | $15.31B | 0.09% |
YYY | 30.69% | $569.04M | 3.25% |
BLCN | 30.69% | $46.71M | 0.68% |
PID | 30.13% | $841.60M | 0.53% |
IWC | 30.04% | $824.65M | 0.6% |
FHLC | 29.86% | $2.43B | 0.084% |
IHE | 29.27% | $557.07M | 0.39% |
IXJ | 29.19% | $3.74B | 0.41% |
HEQT | 29.04% | $330.55M | 0.44% |
EPP | 29.03% | $1.86B | 0.48% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EDV | -0.10% | $3.48B | 0.05% |
CANE | 0.19% | $10.44M | 0.29% |
ZROZ | 0.28% | $1.51B | 0.15% |
SHYD | -0.29% | $332.20M | 0.35% |
HYD | 0.34% | $3.30B | 0.32% |
TLT | 0.52% | $48.88B | 0.15% |
IVOL | 0.54% | $349.27M | 1.02% |
SPTS | -0.59% | $5.78B | 0.03% |
AGZ | 0.63% | $614.02M | 0.2% |
FXY | 0.67% | $815.67M | 0.4% |
IBD | -0.77% | $384.79M | 0.43% |
GSST | -0.84% | $918.38M | 0.16% |
SCHQ | -0.86% | $756.36M | 0.03% |
SPTL | 0.99% | $11.61B | 0.03% |
VGLT | 1.15% | $9.82B | 0.04% |
GOVI | 1.18% | $927.22M | 0.15% |
GOVT | -1.21% | $27.51B | 0.05% |
IBTG | -1.33% | $1.92B | 0.07% |
GOVZ | -1.44% | $270.29M | 0.1% |
AGZD | 1.46% | $102.66M | 0.23% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HRZN | -20.05% | - | - | 18.58% |
WNC | -19.18% | $450.52M | -50.73% | 2.97% |
WERN | -10.42% | $1.70B | -22.97% | 2.07% |
IMNN | -8.83% | $15.04M | -36.21% | 0.00% |
PINC | -7.67% | $1.78B | +15.75% | 3.86% |
SRDX | -6.78% | $411.96M | -31.47% | 0.00% |
HSY | -6.56% | $33.83B | -9.16% | 3.28% |
STG | -6.51% | $29.06M | -28.79% | 0.00% |
ANGI | -6.01% | $756.28M | -17.92% | 0.00% |
SON | -5.97% | $4.32B | -13.60% | 4.77% |
LINE | -5.50% | $10.08B | -43.47% | 3.28% |
K | -5.13% | $27.41B | +36.96% | 2.88% |
LRN | -5.10% | $6.34B | +106.55% | 0.00% |
GRMN | -5.09% | $40.12B | +27.89% | 1.52% |
IP | -5.02% | $25.01B | +9.78% | 3.93% |
OSCR | -5.02% | $5.20B | +29.01% | 0.00% |
SHEN | -4.96% | $750.45M | -16.23% | 0.73% |
FARO | -4.72% | $849.75M | +174.94% | 0.00% |
KE | -4.55% | $468.84M | -12.51% | 0.00% |
VICR | -4.25% | $2.11B | +40.71% | 0.00% |
Current Value
$5.791 Year Return
Current Value
$5.791 Year Return
Finnhub
Abeona Therapeutics Inc. announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, has exercised its option to license Abeona's patented AAV204 capsid for...
Yahoo
Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royaltiesCLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, has exercised its option to license Abeona's patented AAV204 capsid for use in potential gene therapies for a range of prevalent and rare retinal diseases that result in blindness. This worldwide
Yahoo
CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On June 30, 2025, the Compensation Committee of Abeona’s Board of Directors granted restricted stock equity awards as a material inducement to employment to 21 individuals hired by Abeona, which equity awards relate to, in the aggre
Finnhub
Abeona Therapeutics Inc. added to Russell 3000 Value Index...
Finnhub
Abeona Therapeutics Inc. added to Russell 3000 Growth Index...
Finnhub
Abeona Therapeutics Inc. added to Russell 2000 Dynamic Index...